English

BioStock: BiBB's CMO comments on promising results in bladder cancer

Report this content

Lund-based BiBBInstruments continues to deliver positive study results, this time with EndoDrill URO. The results show that the device can safely take treatment-deciding tissue samples earlier in the diagnostic process in the case of suspicion of bladder cancer. BioStock spoke with CMO Dr Charles Walther, who tells more about the potential within the indication. 

Read the interview with CMO Charles Walther at biostock.se:

https://www.biostock.se/en/2023/06/bibbs-cmo-comments-on-promising-results-in-bladder-cancer

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock: BiBB's CMO comments on promising results in bladder cancer
Tweet this